Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-21

Clinical Trial Update: A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed Condition [Phase 1]

View source ↗

Summary

Phase 1 trial assessing relative bioavailability of three formulations under fasted and fed conditions in healthy volunteers, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AstraZeneca

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-08-21